Work

Effectiveness of Switching from Erythropoiesis-Stimulating Agents to Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors in Nondialysis-Dependent Patients with CKD: Reach-J CKD Cohort Study

Year: 2025

Type: article

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.202560s3prvq

Authors: Kunihiro Yamagata, Tomohiro Ohigashi, Chie Saito, Hirayasu Kai, Ryoya Tsunoda, Reiko Okubo, Masahide Kondo, Haruka Ishii, Masami Inuzuka, Kenji Harada, Ichiei Narita, Hirokazu Okada, Takashi Wada, Shoichi Maruyama, Junichi Hoshino

Institutions: Tokyo University of Science, Kyowa Kirin (Japan), Nagoya University

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416865882

FWCI:

Cites:

Cited by:

Related to: 10